GLIAPHARM SA

City:

Geneva

Country:

Switzerland

Published Applications:

Last publication date:

2023-03-30

Patent Grants:

Last grant date:

2024-03-12

Top Inventors for applications by GLIAPHARM SA

These are the the leading inventors for applications assigned to GLIAPHARM SA:

Charles FINSTERWALD 3 Geneva, Switzerland
Pierre MAGISTRETTI 3 Geneva, Switzerland
Sylvain LENGACHER 3 Geneva, Switzerland
PIERRE MAGISTRETTI 1 CRANS-MONTANA, Switzerland

Sylvain Lengacher 1 Lausanne, Switzerland
Sylvain Lengacher 1 Lausanne 26, Switzerland
TIMOTHY JOHN RITCHIE 1 ST ALBANS, United Kingdom
CHARLES FINSTERWALD 1 VEYRIER, Switzerland

Recent patent applications by GLIAPHARM SA

GLIAPHARM SA based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-03-30 ✅ Patent 11,925,632 granted on 2024-03-12

US20230102415A1

Human necessities

Isoquinoline derivatives for use in treating GLUT1 deficiency syndrome

#2 | 2022-02-10 ✅ Patent 12,274,703 granted on 2025-04-15

US20220040197A1

Human necessities

Compositions and methods of treatment for neurological disorders comprising a dementia

#3 | 2022-02-10 ✅ Patent 12,310,967 granted on 2025-05-27

US20220040189A1

Human necessities

Compositions and methods of treatment for neurological disorders comprising motor neuron diseases

#4 | 2022-02-10 ✅ Patent 12,433,892 granted on 2025-10-07

US20220040186A1

Human necessities

COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING DEPRESSION

Also check out GLIAPHARM SA's (Geneva, Switzerland) applicant profile with 4 patent applications submitted.

AssigneeID:

609929 ⎘